BEGIN:VCALENDAR VERSION:2.0 PRODID:-//jEvents 2.0 for Joomla//EN CALSCALE:GREGORIAN METHOD:PUBLISH BEGIN:VTIMEZONE TZID:America/New_York X-LIC-LOCATION:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:19700308T020000 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:19701101T020000 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD END:VTIMEZONE BEGIN:VEVENT UID:6fd281ef725b720a984ed1e4ff4ca638185 CATEGORIES:Events SUMMARY:2021-04_FDA and the pandemic: What’s next, and what’s here to stay DESCRIPTION:
The FDA has undergone significant changes and faced significant challeng es during the pandemic. In this presentation, researchers from POLITICO’s r egulatory intelligence division, AgencyIQ, will highlight some of the bigge st changes made by the FDA and discuss how the agency is likely to change f urther in the near future.”
Speakers:
Alexander Gaffney, MS, RAC
Alexander Gaffney is th e Head of Research at POLITICO’s AgencyIQ, where he leads the team’s resear ch and analysis of life sciences regulatory issues affecting the Food and D rug Administration. Alexander previously worked at PricewaterhouseCoopers w here he led analysis of life sciences regulatory issues for the firm’s pres tigious Health Research Institute. Before joining PwC, he was the Manager o f Regulatory Intelligence at the Regulatory Affairs Professionals Society ( RAPS), where he also was Managing Editor of the company’s flagship publicat ion, Regulatory Focus. Alexander has a Master’s degree in Regulatory Scienc e and his Regulatory Affairs Certification (RAC) in US regulation.
Kirsten Messmer, PhD, RAC
Kir sten Messmer, PhD, RAC is a Senior Research Analyst and contributes to the research and development of content for Agency IQ. Prior to joining Agency IQ, she was a Principal Regulatory Affairs Specialist at PPD providing glob al regulatory intelligence to support efficient, compliant and successful c linical research and drug development for biopharmaceuticals and advanced t herapies. Kirsten received her PhD in Neuroscience from the University of S heffield (Sheffield, UK) and a Biology Diplom from the Eberhard-Karls Unive rsity (Tübingen, Germany). Kirsten also holds a Regulatory Affairs Certific ation (RAC) in US regulation.
Laura DiAngelo, MPH
Laura DiAngelo is a Senior Research Manager on the AgencyIQ team. She contributes to the research and development of cont ent for Agency IQ, with an emphasis on medical device and diagnostics regul atory intelligence. Before joining POLITICO, Laura consulted on policy and regulatory issues for life sciences and health plan clients with Avalere He alth, and managed content for the Avalere Policy and State Reform 360® busi ness intelligence research products. She holds a MPH in health care policy from the George Washington University’s Milken School of Public Health.
CONTACT:programs@ncraf.org DTSTAMP:20240329T155906 DTSTART;TZID=America/New_York:20210422T183000 DTEND;TZID=America/New_York:20210422T200000 SEQUENCE:0 TRANSP:OPAQUE END:VEVENT END:VCALENDAR